vs
Side-by-side financial comparison of RxSight, Inc. (RXST) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $32.6M, roughly 1.4× RxSight, Inc.). RxSight, Inc. runs the higher net margin — -28.1% vs -33.9%, a 5.8% gap on every dollar of revenue. On growth, STEM, INC. posted the faster year-over-year revenue change (-15.6% vs -18.9%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 5.1%).
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
RXST vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.6M | $47.1M |
| Net Profit | $-9.2M | $-16.0M |
| Gross Margin | 77.5% | 48.9% |
| Operating Margin | -34.8% | -17.7% |
| Net Margin | -28.1% | -33.9% |
| Revenue YoY | -18.9% | -15.6% |
| Net Profit YoY | -54.1% | 68.8% |
| EPS (diluted) | $-0.22 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.6M | $47.1M | ||
| Q3 25 | $30.3M | $38.2M | ||
| Q2 25 | $33.6M | $38.4M | ||
| Q1 25 | $37.9M | $32.5M | ||
| Q4 24 | $40.2M | $55.8M | ||
| Q3 24 | $35.3M | $29.3M | ||
| Q2 24 | $34.9M | $34.0M | ||
| Q1 24 | $29.5M | $25.5M |
| Q4 25 | $-9.2M | $-16.0M | ||
| Q3 25 | $-9.8M | $-23.8M | ||
| Q2 25 | $-11.8M | $202.5M | ||
| Q1 25 | $-8.2M | $-25.0M | ||
| Q4 24 | $-5.9M | $-51.1M | ||
| Q3 24 | $-6.3M | $-148.3M | ||
| Q2 24 | $-6.1M | $-582.3M | ||
| Q1 24 | $-9.1M | $-72.3M |
| Q4 25 | 77.5% | 48.9% | ||
| Q3 25 | 79.9% | 35.5% | ||
| Q2 25 | 74.9% | 33.4% | ||
| Q1 25 | 74.8% | 32.4% | ||
| Q4 24 | 71.6% | -4.4% | ||
| Q3 24 | 71.4% | 21.2% | ||
| Q2 24 | 69.5% | 27.6% | ||
| Q1 24 | 70.1% | -95.0% |
| Q4 25 | -34.8% | -17.7% | ||
| Q3 25 | -40.1% | -33.6% | ||
| Q2 25 | -41.6% | -34.8% | ||
| Q1 25 | -28.2% | -65.0% | ||
| Q4 24 | -21.5% | -84.4% | ||
| Q3 24 | -26.1% | -493.2% | ||
| Q2 24 | -23.9% | -1705.5% | ||
| Q1 24 | -36.2% | -267.0% |
| Q4 25 | -28.1% | -33.9% | ||
| Q3 25 | -32.4% | -62.2% | ||
| Q2 25 | -35.0% | 527.8% | ||
| Q1 25 | -21.6% | -76.9% | ||
| Q4 24 | -14.8% | -91.6% | ||
| Q3 24 | -17.9% | -506.3% | ||
| Q2 24 | -17.4% | -1712.6% | ||
| Q1 24 | -30.8% | -283.9% |
| Q4 25 | $-0.22 | $-4.40 | ||
| Q3 25 | $-0.24 | $-2.84 | ||
| Q2 25 | $-0.29 | $-1.79 | ||
| Q1 25 | $-0.20 | $-0.15 | ||
| Q4 24 | $-0.14 | $-15.29 | ||
| Q3 24 | $-0.16 | $-18.24 | ||
| Q2 24 | $-0.16 | $-71.81 | ||
| Q1 24 | $-0.25 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.1M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $275.7M | $-249.4M |
| Total Assets | $311.8M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $228.1M | $48.9M | ||
| Q3 25 | $227.5M | $43.1M | ||
| Q2 25 | $227.5M | $40.8M | ||
| Q1 25 | $229.3M | $58.6M | ||
| Q4 24 | $237.2M | $56.3M | ||
| Q3 24 | $237.1M | $75.4M | ||
| Q2 24 | $233.3M | $89.6M | ||
| Q1 24 | $125.4M | $112.8M |
| Q4 25 | $275.7M | $-249.4M | ||
| Q3 25 | $276.0M | $-235.7M | ||
| Q2 25 | $278.0M | $-214.1M | ||
| Q1 25 | $279.3M | $-417.5M | ||
| Q4 24 | $281.2M | $-398.4M | ||
| Q3 24 | $277.3M | $-344.1M | ||
| Q2 24 | $275.2M | $-203.2M | ||
| Q1 24 | $163.9M | $371.6M |
| Q4 25 | $311.8M | $308.9M | ||
| Q3 25 | $308.5M | $362.6M | ||
| Q2 25 | $309.0M | $379.2M | ||
| Q1 25 | $313.0M | $405.1M | ||
| Q4 24 | $318.6M | $437.4M | ||
| Q3 24 | $310.5M | $537.8M | ||
| Q2 24 | $305.5M | $691.5M | ||
| Q1 24 | $183.2M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $8.2M |
| Free Cash FlowOCF − Capex | $-2.3M | — |
| FCF MarginFCF / Revenue | -6.9% | — |
| Capex IntensityCapex / Revenue | 3.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-19.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | $8.2M | ||
| Q3 25 | $-1.2M | $11.4M | ||
| Q2 25 | $-4.4M | $-21.3M | ||
| Q1 25 | $-8.8M | $8.5M | ||
| Q4 24 | $-4.3M | $-14.7M | ||
| Q3 24 | $650.0K | $-9.4M | ||
| Q2 24 | $-4.0M | $-11.9M | ||
| Q1 24 | $-9.3M | $-621.0K |
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-5.9M | — | ||
| Q1 25 | $-9.4M | — | ||
| Q4 24 | $-5.1M | — | ||
| Q3 24 | $-453.0K | — | ||
| Q2 24 | $-5.5M | — | ||
| Q1 24 | $-11.3M | — |
| Q4 25 | -6.9% | — | ||
| Q3 25 | -5.8% | — | ||
| Q2 25 | -17.6% | — | ||
| Q1 25 | -24.8% | — | ||
| Q4 24 | -12.7% | — | ||
| Q3 24 | -1.3% | — | ||
| Q2 24 | -15.9% | — | ||
| Q1 24 | -38.2% | — |
| Q4 25 | 3.5% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 3.1% | — | ||
| Q2 24 | 4.4% | — | ||
| Q1 24 | 6.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
STEM
Segment breakdown not available.
